Mualliflar

  • Tuychieva K.D.

##semicolon##

chronic endometritis, infertility, reproductive outcomes.

##submission.citations##

Al-Saadi H. et al. Low-level laser therapy and PRP in CE rehabilitation. Lasers Med Sci. 2024; 39(3):765–773.

Aslan B. et al. Histopathological Association Between Chronic Endometritis and Adenomyosis. J Obstet Gynaecol Res. 2025.

Bouet P.E. et al. High prevalence of CE in patients with hydrosalpinx. J Minim Invasive Gynecol. 2025.

Delgado J., Ruiz M. AI-assisted histopathological diagnosis of CE. Comput Biol Med. 2024;174: 108012.

Fedorova E., Kiseleva O. Cytokine profiling for precision therapy in CE. Obstet Gynecol Reprod. 2025;19(1):51–58.

Feng L., Zhao Y. et al. TLR4/NFκB signaling activation in CE endometrium. J Reprod Immunol. 2023;158:104811.

Gonzalez R., Silva C. Regenerative endometrial therapy using mesenchymal stem cells in CE. Stem Cells Transl Med. 2025;14(3):145–157.

Guo J., Chang Y., Zeng Z. Chronic endometritis incidence in infertile women with PCOS. BMC Women’s Health. 2023;23:628.

Huang J. et al. Chronic endometritis multiplies recurrence risk of endometrial polyps. BMC Women’s Health. 2024.

Jia Y., Hu X. et al. Altered HOXA10–LIF–Integrin β3 axis in chronic endometritis-related infertility. Reprod Biol Endocrinol. 2025;23(4):211.

Kang H., Lee Y., Park S. Alterations in endometrial microbiota and immune cytokine balance in chronic endometritis. Front Reprod Health. 2025;3: 1559824.

Kim E., Cho H. et al. Endometrial Lactobacillus deficiency and IL-17 overexpression in CE patients. Reprod Sci. 2024;31(2):432–441.

Kolesnikova T., Mamedova D. Photobiomodulation therapy for chronic endometritis rehabilitation. Reprod Med Biol. 2024;23(7):441–449.

Li J., Zhang J., Chen X. Prevalence of chronic endometritis in infertile women undergoing hysteroscopy. BMC Women’s Health. 2024;24:3245.

Lin S., Xie X., Chen Y. CE influence on pregnancy outcomes in endometriosis-associated infertility. Reprod Health. 2024;21:162.

Petrova N., Ivanova E. Ozone therapy in chronic endometritis: clinical efficacy and safety. Gynecol Endocrinol. 2025;41(2):189–196.

Prevalence and risk factors for CE in intrauterine disorders after hysteroscopic surgery. ASRM. 2022.

Shuang You et al. Collagen-based immunotherapy reduces fibrosis in CE model. J Tissue Eng Regen Med. 2023;17(6):835–844.

Tang X., Zhou W. et al. Circulating miRNA and extracellular vesicle biomarkers in chronic endometritis. Int J Mol Sci. 2024;25(8):4519.

Unveiling the silver lining: a narrative review of CE diagnostic strategies. Fertil Steril Rev. 2024.

Vidal A. et al. High risk of CE in isthmocele: a clinical study. J Clin Med. 2025;14(11):3628.

Vitagliano A., Saccardi C. Meta-analysis: reproductive outcomes after CE treatment. Hum Reprod Update. 2022;28(9):1501–1518.

Wang L. et al. Adipose-derived exosomes suppress inflammatory cytokines in CE. Stem Cell Res Ther. 2023;14(1):276.

Xiong Yu-jing, Luo W.-b., Ai X.-x., Xu Y.-w. The Pathogenesis of Chronic Endometritis: A Review. J Int Reprod Health/Family Planning. 2023;42(1): 60–65.

Yamamoto A., Ito T. et al. Probiotic-based intrauterine therapy improves CE outcomes and microbiota recovery. Fertil Steril. 2025;124(5):987–995.

Zhang C., Meng S., Tu X. Analysis of risk factors of chronic endometritis in infertile women. BMC Women’s Health. 2025;25:378.

Challenges in Clinical Diagnosis and Management of CE. Diagnostics (MDPI). 2022;12(11): 2711.

Chronic endometritis and recurrent reproductive failure: a systematic review. Front Immunol. 2024;1427454.